IL6 and graft versus host disease: Im et al. also demonstrated that NecroX-7 attenuates acute graft versus host disease (GvHD) via reciprocal regulation of type 1 helper T cells and regulatory T cells, with inhibition of TNF, interleukin-6 (IL-6), and TLR4 [27].